Literature DB >> 24173134

Experimental cardiac arrest treatment with adrenaline, vasopressin, or placebo.

Manoel Ângelo Gomes Palácio, Edison Ferreira de Paiva, Luciano Cesar Pontes de Azevedo, Ari Timerman.   

Abstract

BACKGROUND: The effect of vasoconstrictors in prolonged cardiopulmonary resuscitation (CPR) has not been fully clarified.
OBJECTIVES: To evaluate adrenaline and vasopressin pressure effect, and observe the return of spontaneous circulation (ROSC).
METHODS: A prospective, randomized, blinded, and placebo-controlled study. After seven minutes of untreated ventricular fibrillation, pigs received two minutes cycles of CPR. Defibrillation was attempted (4 J/kg) once at 9 minutes, and after every cycle if a shockable rhythm was present, after what CPR was immediately resumed. At 9 minutes and every five minutes intervals, 0.02 mg/kg (n = 12 pigs) adrenaline, or 0.4 U/kg (n = 12) vasopressin, or 0.2 mL/kg (n = 8) 0.9% saline solution was administered. CPR continued for 30 minutes or until the ROSC.
RESULTS: Coronary perfusion pressure increased to about 20 mmHg in the three groups. Following vasoconstrictors doses, pressure level reached 35 mmHg versus 15 mmHg with placebo (p < 0.001). Vasopressin effect remained at 15-20 mmHg after three doses versus zero with adrenaline or placebo. ROSC rate differed (p = 0.031) among adrenaline (10/12), vasopressin (6/12), and placebo (2/8). Time-to-ROSC did not differ (16 minutes), nor the number of doses previously received (one or two). There was no difference between vasoconstrictors, but against placebo, only adrenaline significantly increased the ROSC rate (p = 0.019).
CONCLUSION: The vasoconstrictors initial pressure effect was equivalent and vasopressin maintained a late effect at prolonged resuscitation. Nevertheless, when compared with placebo, only adrenaline significantly increased the ROSC rate.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24173134      PMCID: PMC4106812          DOI: 10.5935/abc.20130213

Source DB:  PubMed          Journal:  Arq Bras Cardiol        ISSN: 0066-782X            Impact factor:   2.000


  30 in total

1.  Use of pressors in the treatment of cardiac arrest.

Authors:  C F Babbs; R A Berg; F Kette; W G Kloeck; K H Lindner; K G Lurie; P T Morley; V M Nadkarni; C W Otto; N A Paradis; J Perlman; I Stiell; A Timerman; P Van Reempts; V Wenzel
Journal:  Ann Emerg Med       Date:  2001-04       Impact factor: 5.721

Review 2.  The use of vasopressor agents during cardiopulmonary resuscitation.

Authors:  Kjetil Sunde; Petter Andreas Steen
Journal:  Crit Care Clin       Date:  2011-12-01       Impact factor: 3.598

Review 3.  Part 8: adult advanced cardiovascular life support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.

Authors:  Robert W Neumar; Charles W Otto; Mark S Link; Steven L Kronick; Michael Shuster; Clifton W Callaway; Peter J Kudenchuk; Joseph P Ornato; Bryan McNally; Scott M Silvers; Rod S Passman; Roger D White; Erik P Hess; Wanchun Tang; Daniel Davis; Elizabeth Sinz; Laurie J Morrison
Journal:  Circulation       Date:  2010-11-02       Impact factor: 29.690

4.  Distribution, blood transport, and degradation of antidiuretic hormone in man.

Authors:  G Baumann; J F Dingman
Journal:  J Clin Invest       Date:  1976-05       Impact factor: 14.808

5.  Variable effects of high-dose adrenaline relative to standard-dose adrenaline on resuscitation outcomes according to cardiac arrest duration.

Authors:  Kyung Woon Jeung; Hyun Ho Ryu; Kyung Hwan Song; Byung Kook Lee; Hyoung Youn Lee; Tag Heo; Yong Il Min
Journal:  Resuscitation       Date:  2011-03-23       Impact factor: 5.262

6.  Effect of adrenaline on survival in out-of-hospital cardiac arrest: A randomised double-blind placebo-controlled trial.

Authors:  Ian G Jacobs; Judith C Finn; George A Jelinek; Harry F Oxer; Peter L Thompson
Journal:  Resuscitation       Date:  2011-07-02       Impact factor: 5.262

7.  Developing a vasopressor combination in a pig model of adult asphyxial cardiac arrest.

Authors:  V D Mayr; V Wenzel; W G Voelckel; A C Krismer; T Mueller; K G Lurie; K H Lindner
Journal:  Circulation       Date:  2001-10-02       Impact factor: 29.690

8.  Reduced effectiveness of vasopressin in repeated doses for patients undergoing prolonged cardiopulmonary resuscitation.

Authors:  Takeo Mukoyama; Kosaku Kinoshita; Ken Nagao; Katsuhisa Tanjoh
Journal:  Resuscitation       Date:  2009-05-14       Impact factor: 5.262

Review 9.  Science Review: Vasopressin and the cardiovascular system part 2 - clinical physiology.

Authors:  Cheryl L Holmes; Donald W Landry; John T Granton
Journal:  Crit Care       Date:  2003-06-26       Impact factor: 9.097

Review 10.  Science review: Vasopressin and the cardiovascular system part 1--receptor physiology.

Authors:  Cheryl L Holmes; Donald W Landry; John T Granton
Journal:  Crit Care       Date:  2003-06-26       Impact factor: 9.097

View more
  1 in total

1.  Goal-directed cardiopulmonary resuscitation for refractory out-of-hospital cardiac arrest in the emergency Department: A feasibility study.

Authors:  Byron C Drumheller; Joseph Pinizzotto; Ryan C Overberger; Erin E Sabolick
Journal:  Resusc Plus       Date:  2021-08-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.